Select a community
ALS including PLS and PMA
Find out more about the PatientsLikeMe
ALS Community
Home > Community Treatment Reports > Tolterodine Treatment Report
What is Tolterodine?

Tolterodine is an anticholinergic agent used for the treatment of patients with an overactive bladder with symptoms of urinary frequency, urgency, or urge incontinence.

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken # of patients Major Moderate Slight None Can’t tell # of patients evaluated by
Other 9 2
Urinary urgency 6 2
General health 3 0
Bladder problems 3 0
Slow my ALS progress 1 0

Mouse over the table for more information

Side Effects

Side effects as an overall problem

Severe
0 0%
Moderate
0 0%
Mild
1 25%
None
3 75%

Most commonly reported side effects

dry mouth
1 25%
Constipation
1 25%
Dry eyes
1 25%
  • Mild
  • Moderate
  • Severe

Dosages

  1 mg daily 2 mg daily 3 mg daily 4 mg daily 40 mg daily
  2 Number of Patients: 2 4 Number of Patients: 4 1 Number of Patients: 1 9 Number of Patients: 9 1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking Tolterodine (multiple reasons could be selected)
Reason # Patients Percentage of patients
Doctor's advice
4 50% Doctor's advice: 50%
Did not seem to work
3 38% Did not seem to work: 38%
Other
1 13% Other: 13%
Course of treatment ended
1 13% Course of treatment ended: 13%
Not indicated
1 13% Not indicated: 13%

See all 8 patients who’ve stopped taking Tolterodine

Currently Taking Tolterodine

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
1
0
1
3
1
2

Stopped Taking Tolterodine

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
1
1
2
1
3

Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Always
3 75%
Usually
1 25%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
0 0%
A little
1 25%
Not at all
3 75%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
1 25%

See more information, including instructions, precautions, side effects, and interactions.

Report created on November 22, 2009.